IL13 and inflammation: Prior work has shown that expression of cathelicidin and β-defensin AMPs is decreased by the action of Th2 cytokines such as IL-4 and IL-13.10–12 However, the skin during Th2 inflammation still has a partial increase in host defense gene expression.